Gupta Mukesh K, Lee Yunki, Boire Timothy C, Lee Jung-Bok, Kim Won Shik, Sung Hak-Joon
Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, US.
Department of Otorhinolaryngology, Yonsei University, College of Medicine, South Korea.
Nanotheranostics. 2017 Apr 6;1(2):166-177. doi: 10.7150/ntno.18531. eCollection 2017.
Vascular disease is a leading cause of death and disability worldwide. Current surgical intervention and treatment options for vascular diseases have exhibited limited long-term success, emphasizing the need to develop advanced treatment paradigms for early detection and more effective treatment of dysfunctional cells in a specific blood vessel lesion. Advances in targeted nanoparticles mediating cargo delivery enables more robust prevention, screening, diagnosis, and treatment of vascular disorders. In particular, nanotheranostics integrates diagnostic imaging and therapeutic function into a single agent, and is an emerging platform towards more effective and localized vascular treatment. This review article highlights recent advances and current challenges associated with the utilization of targeted nanoparticles for real-time diagnosis and treatment of vascular diseases. Given recent developments, nanotheranostics offers great potential to serve as an effective platform for targeted, localized, and personalized vascular treatment.
血管疾病是全球死亡和残疾的主要原因。目前针对血管疾病的手术干预和治疗方案长期成功率有限,这凸显了开发先进治疗模式以早期检测特定血管病变中功能失调细胞并进行更有效治疗的必要性。靶向纳米颗粒介导的药物递送技术的进步,使血管疾病的预防、筛查、诊断和治疗更加有力。特别是,纳米诊疗技术将诊断成像和治疗功能整合到单一制剂中,是实现更有效、局部化血管治疗的新兴平台。本文综述强调了利用靶向纳米颗粒进行血管疾病实时诊断和治疗的最新进展及当前挑战。鉴于近期的发展,纳米诊疗技术有很大潜力成为靶向、局部化和个性化血管治疗的有效平台。